Artificial Differences in Clostridium difficile Infection Rates Associated with Disparity in Testing

Authors:
  • JBJennifer Brite
    Jennifer Brite
  • AAAnoshe Aslam
    Anoshe Aslam
  • JKJessica Kennington
    Jessica Kennington
  • NBN. Esther Babady
    N. Esther Babady
  • DCDavid Calfee
    David Calfee
  • YFYoko Furuya
    Yoko Furuya
  • DCDonald Chen
    Donald Chen
  • MAMichael Augenbraun
    Michael Augenbraun
  • BOBelinda Ostrowsky
    Belinda Ostrowsky
  • GPGopi Patel
    Gopi Patel
  • MMMonica Mircescu
    Monica Mircescu

Abstract
In 2015, Clostridium difficile testing rates among 30 US community, multispecialty, and cancer hospitals were 14.0, 16.3, and 33.9/1,000 patient-days, respectively. Pooled hospital onset rates were 0.56, 0.84, and 1.57/1,000 patient-days, respectively. Higher testing rates may artificially inflate reported rates of C. difficile infection. C. difficile surveillance should consider testing frequency.

This publication has 12 references indexed in Scilit: